Floatz logo

Lovastatin

Jaundice

Columbia UniversitySmall moleculePhase 2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Jaundice cohort.

Asset / SponsorPhaseRating
g17dt
Cancer Advances Inc.
Phase 2B
Photofrin
Samsung Medical Center
N/ANR

Same molecule, other indications

Lovastatin is also rated in:

stroke disorderDormant
CC
Indicative ·
47 / 100
View asset →
Malignant MelanomaDormant
CC
Indicative ·
47 / 100
View asset →
precancerous conditionDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →